Fisher & Paykel Healthcare can’t predict the future

Fisher & Paykel Healthcare can’t predict the future
Chief executive Lewis Gradon told analysts there was a big opportunity ahead but couldn't say when the company would reach it. (Photo: Supplied)
Dan Brunskill
Medical device manufacturer Fisher & Paykel Healthcare is unquestionably in a better position than it was pre-covid, the question everyone is asking is: how much better? It was a question that not even chief executive Lewis Gradon was able to answer when asked by analysts after reporting earnings on Wednesday. The company declined to give earnings guidance for the third straight year, saying it was too hard to predict how much stock customers would want to hold and the possibility of future covid-19 surges.Unable to give guidance,...

More Markets

Fisher & Paykel Healthcare helps NZX up 1%
Markets Market Close

Fisher & Paykel Healthcare helps NZX up 1%

Skellerup Holdings shares rose 5.1%. 

Warehouse drops guidance, loss now in scope
Retail

Warehouse drops guidance, loss now in scope

The retailer has raised the possibility of a full-year earnings loss.

Xero’s Melio ‘leap of faith’
Markets Analysis

Xero’s Melio ‘leap of faith’

The NZ-founded company’s giant-killer dreams in the US hinge on this huge bet.